Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Symbol Lookup |
|
CLOSEX
Investing just got easier…Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now |
Key Stock Data
Intraday Chart
Trading Range
The current last sale of $22.32
| Intraday | Last 52 Weeks | |
| High: | $ 22.45 | $ 21.35 |
| Low: | $ 19.23 | $ 4.72 |
Company Description (as filed with the SEC)
We are a leader in the field of gene therapy, seeking to develop single treatments with potentially curative results for patients suffering from genetic and other devastating diseases. We are advancing a focused pipeline of innovative gene therapies that have been developed both internally and through partnerships, such as our collaboration with Bristol Myers-Squibb focused on cardiovascular diseases. We have established clinical proof-of-concept in our lead indication, hemophilia B and achieved preclinical proof-of-concept in Huntington's disease. We believe our validated technology platform and manufacturing capabilities provide us distinct competitive advantages, including the potential to reduce development risk, cost and time to market. We produce our AAV-based gene therapies in our own facilities with a proprietary, commercial-scale, consistent, manufacturing process. ... More ...
Nasdaq Official Price
|
Open Price:
$ 19.41 |
Open Date:
Feb. 12, 2018 |
|
|
Close Price:
$ 22.32 |
Close Date:
Feb. 12, 2018 |
